China Biologics Market Size, Share, Trends & Forecast

The China Biologics Market is expanding rapidly as demand for targeted therapies, personalized medicine, and advanced biological treatments increases across the country. According to Market Research Future, the market was valued at USD 46.22 billion in 2024 and is projected to reach USD 278.42 billion by 2035, registering a CAGR of 17.73% during 2025–2035.

China's aging population and increasing prevalence of chronic diseases are creating substantial demand for biologic medicines. Oncology and autoimmune disorders are particularly important areas, while advances in biotechnology are expanding treatment possibilities.

Government support for biopharmaceutical innovation, increasing healthcare investment, and improvements in domestic manufacturing capabilities are further supporting market development.

Read More
Lukoon https://lukoon.com